HCA Healthcare, Inc. $HCA Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 9.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,506 shares of the company’s stock after selling 1,919 shares during the quarter. State of Alaska Department of Revenue’s holdings in HCA Healthcare were worth $7,461,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in HCA. Chung Wu Investment Group LLC acquired a new stake in HCA Healthcare during the second quarter worth $27,000. Clearstead Trust LLC boosted its position in shares of HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares during the period. Ameriflex Group Inc. acquired a new position in HCA Healthcare during the second quarter worth $27,000. Harbor Capital Advisors Inc. grew its stake in shares of HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after buying an additional 34 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new position in HCA Healthcare during the 2nd quarter worth about $40,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently issued reports on HCA shares. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 25th. Mizuho increased their target price on shares of HCA Healthcare from $505.00 to $520.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. Jefferies Financial Group boosted their price target on shares of HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. The Goldman Sachs Group lifted their target price on HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a report on Monday, October 27th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $503.00 price target on shares of HCA Healthcare in a research report on Tuesday. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $485.95.

Insider Buying and Selling

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by corporate insiders.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA is among the first health systems to access OpenAI’s new healthcare programs — a move that could drive clinical efficiency, faster workflow automation and potential cost savings if deployed broadly across HCA’s network. HCA Healthcare among first to access OpenAI’s new health care programs
• Positive Sentiment: OpenAI launched ChatGPT for Healthcare at several large systems — broader industry adoption reduces implementation risk and can accelerate HCA’s rollout benefits (clinical decision support, patient triage, revenue-cycle automation). OpenAI launches ChatGPT for Healthcare at several large health systems
• Positive Sentiment: HCA and AdventHealth are expanding ER footprints in Florida — inorganic/greenfield capacity additions should help volume growth and market share in a high-margin service line. HCA, AdventHealth expand Florida ER footprints
• Positive Sentiment: A new emergency facility opened in Arlington — incremental capacity and local access that can lift admissions and outpatient revenues. New emergency health facility opens in Arlington
• Positive Sentiment: HCA Florida Capital Hospital and UCF launched a medical residency program — strengthens physician pipeline and could reduce staffing pressures/costs over time. HCA Florida Capital Hospital, UCF create new medical residency program
• Positive Sentiment: An analyst raised HCA’s price target to $520 — a bullish signal that supports upside in the medium term if execution and margins track. HCA Healthcare (NYSE:HCA) Price Target Raised to $520.00
• Neutral Sentiment: HCA Georgia hospital named a new CFO — routine executive hire that supports local operations but is not material company‑wide. HCA Georgia hospital taps CFO
• Neutral Sentiment: HCA rolled out a “Talk to a nurse for free” service — positive PR and access initiative but limited immediate financial impact. HCA says: ‘Talk to a nurse for free’
• Negative Sentiment: CEO exit after nine months at an HCA Virginia behavioral health hospital — leadership turnover can signal integration or operational issues in a growing behavioral-health segment. HCA Virginia behavioral health hospital CEO exits after 9 months
• Negative Sentiment: A MarketWatch note flagged HCA’s relative underperformance versus peers on a recent trading day — highlights near‑term downside risk if investors rotate into other healthcare names. HCA Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains

HCA Healthcare Price Performance

NYSE:HCA opened at $472.40 on Friday. The firm has a market capitalization of $107.80 billion, a PE ratio of 18.26, a price-to-earnings-growth ratio of 1.32 and a beta of 1.36. The business’s fifty day moving average price is $479.87 and its 200 day moving average price is $427.05. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $520.00.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, December 29th. Stockholders of record on Monday, December 15th were issued a $0.72 dividend. The ex-dividend date was Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.